Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
Summary: Glucagon-like peptide-1 receptor (GLP-1R) agonists used to treat type 2 diabetes mellitus often produce nausea, vomiting, and in some patients, undesired anorexia. Notably, these behavioral effects are caused by direct central GLP-1R activation. Herein, we describe the creation of a GLP-1R...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2020-06-01
|
| Serier: | Cell Reports |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2211124720307488 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
